• FDA clears Amgen’s Prolia for glucocorticoid osteoporosis pharmatimes
    May 24, 2018
    The decision allows physicians to prescribe the drug to patients with a history of osteoporotic fracture, those with multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy.
PharmaSources Customer Service